Form 8-K - Current report:
SEC Accession No. 0001829126-25-000818
Filing Date
2025-02-10
Accepted
2025-02-10 08:35:24
Documents
14
Period of Report
2025-02-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K zeoscientifix_8k.htm   iXBRL 8-K 53832
2 EXHIBIT 10.1 zeoscientifix_ex10-1.htm EX-10.1 69887
  Complete submission text file 0001829126-25-000818.txt   313167

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE ocel-20250204.xsd EX-101.SCH 2991
4 XBRL LABEL FILE ocel-20250204_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE ocel-20250204_pre.xml EX-101.PRE 22343
16 EXTRACTED XBRL INSTANCE DOCUMENT zeoscientifix_8k_htm.xml XML 3346
Mailing Address 3321 COLLEGE AVENUE SUITE 246 DAVIE FL 33314
Business Address 3321 COLLEGE AVENUE SUITE 246 DAVIE FL 33314 888-963-7881
Zeo ScientifiX, Inc. (Filer) CIK: 0001557376 (see all company filings)

EIN.: 474180540 | State of Incorp.: NV | Fiscal Year End: 1031
Type: 8-K | Act: 34 | File No.: 000-55008 | Film No.: 25603770
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)